Status:

RECRUITING

Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma

Lead Sponsor:

Institut Claudius Regaud

Collaborating Sponsors:

NovoCure Ltd.

Conditions:

Glioblastoma

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This trial is a translational, open-label, monocentric prospective study of 80 patients aiming to study resistance mechanisms as well as biomarkers of resistance or sensitivity to TTFields. The study...

Eligibility Criteria

Inclusion

  • Age ≥18 years at the time of study entry.
  • Patient with newly diagnosed glioblastoma.
  • Patient for which a treatment with radio-chemotherapy followed by TTFields has been decided and has not been started.
  • Signed written informed consent.
  • Patient able to participate and willing to give informed consent prior performance of any study-related procedures and to comply with the study protocol
  • Patient affiliated to a Social Health Insurance in France.

Exclusion

  • Any condition contraindicated with sampling procedures required by the protocol.
  • Any contraindication to the use of the medical device administering TTFields.
  • Simultaneous participation in a therapeutic interventional clinical trial.
  • Patient pregnant, or breast-feeding.
  • Known history of positive test for hepatitis B virus or hepatitis C virus or human immunodeficiency virus (HIV) or known acquired immunodeficiency syndrome (AIDS).
  • Any psychological, familial, geographic or social situation, according to the judgment of investigator, potentially preventing the provision of informed consent or compliance to study procedure
  • Patient who has forfeited his/her freedom by administrative or legal award or who is under legal protection (curatorship and guardianship, protection of justice)

Key Trial Info

Start Date :

August 27 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2028

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT06222138

Start Date

August 27 2024

End Date

May 1 2028

Last Update

June 5 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

IUCT-O

Toulouse, France